Donegan Michael C

Prin. Fin. and Acctg. OfficerTherapeuticsMD, Inc. (TXMD) · full profile →Form 4 · filed Jan 25, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
10
6 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 24, 2023Sell(S)7$5.31$378K
Jan 23, 2023Sell(S)1K$5.34$7K8K
Jan 23, 2023Option exercise(M)1K$06K
Jan 23, 2023Option exercise(M)380$05K
Jan 23, 2023Option exercise(M)519$07K
Jan 23, 2023Option exercise(M)2K$09K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 23, 2023Option exercise(M)380$00
Jan 23, 2023Option exercise(M)1K$00
Jan 23, 2023Option exercise(M)2K$00
Jan 23, 2023Option exercise(M)519$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-004871) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.